| Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage DE Pellegrini-Giampietro, G Cherici, M Alesiani, V Carla, F Moroni Journal of Neuroscience 10 (3), 1035-1041, 1990 | 667 | 1990 |
| Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites F Moroni European journal of pharmacology 375 (1-3), 87-100, 1999 | 426 | 1999 |
| Adenosine decreases aspartate and glutamate release from rat hippocampal slices R Corradetti, GL Conte, F Moroni, MB Passani, G Pepeu European journal of pharmacology 104 (1-2), 19-26, 1984 | 423 | 1984 |
| Presence of kynurenic acid in the mammalian brain F Moroni, P Russi, G Lombardi, M Beni, V Carla Journal of neurochemistry 51 (1), 177-180, 1988 | 310 | 1988 |
| Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain G Faraco, T Pancani, L Formentini, P Mascagni, G Fossati, F Leoni, ... Molecular pharmacology 70 (6), 1876-1884, 2006 | 286 | 2006 |
| Excitatory amino acid release from rat hippocampal slices as a consequence of free‐radical formation DE Pellegrini‐Giampietro, G Cherici, M Alesiani, V Carlà, F Moroni Journal of neurochemistry 51 (6), 1960-1963, 1988 | 281 | 1988 |
| GM1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system G Toffano, G Savoini, F Moroni, G Lombardi, L Calza, LF Agnati Brain Research 261 (1), 163-166, 1983 | 277 | 1983 |
| High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo G Faraco, S Fossati, ME Bianchi, M Patrone, M Pedrazzi, B Sparatore, ... Journal of neurochemistry 103 (2), 590-603, 2007 | 269 | 2007 |
| Presynaptic kynurenate‐sensitive receptors inhibit glutamate release R Carpenedo, A Pittaluga, A Cozzi, S Attucci, A Galli, M Raiteri, F Moroni European Journal of Neuroscience 13 (11), 2141-2147, 2001 | 269 | 2001 |
| Clinical pharmacokinetics of valproic acid—1988 G Zaccara, A Messori, F Moroni Clinical pharmacokinetics 15, 367-389, 1988 | 261 | 1988 |
| Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool M Pittelli, L Formentini, G Faraco, A Lapucci, E Rapizzi, F Cialdai, ... Journal of Biological Chemistry 285 (44), 34106-34114, 2010 | 221 | 2010 |
| Pharmacological characterization of 1-aminoindan-1, 5-dicarboxylic acid, a potent mGluR1 antagonist F Moroni, G Lombardi, C Thomsen, P Leonardi, S Attucci, F Peruginelli, ... Journal of Pharmacology and Experimental Therapeutics 281 (2), 721-729, 1997 | 215 | 1997 |
| Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery F Moroni, A Cozzi, M Sili, G Mannaioni Journal of neural transmission 119, 133-139, 2012 | 203 | 2012 |
| Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases NA Berger, VC Besson, AH Boulares, A Bürkle, A Chiarugi, RS Clark, ... British journal of pharmacology 175 (2), 192-222, 2018 | 197 | 2018 |
| 1-Aminoindan-1, 5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors R Pellicciari, R Luneia, G Costantino, M Marinozzi, B Natalini, P Jakobsen, ... Journal of medicinal chemistry 38 (19), 3717-3719, 1995 | 196 | 1995 |
| Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities R Carpenedo, A Chiarugi, P Russi, G Lombardi, V Carlà, R Pellicciari, ... Neuroscience 61 (2), 237-244, 1994 | 195 | 1994 |
| Poly (ADP-ribose) polymerase 1 (PARP-1) and postischemic brain damage F Moroni Current opinion in pharmacology 8 (1), 96-103, 2008 | 194 | 2008 |
| Kynurenine Hydroxylase Inhibitors Reduce Ischemic Brain Damage: Studies with (m-Nitrobenzoyl)-Alanine (mNBA) and 3,4-Dimethoxy-[-N-4-(Nitrophenyl)Thiazol … A Cozzi, R Carpenedo, F Moroni Journal of Cerebral Blood Flow & Metabolism 19 (7), 771-777, 1999 | 190 | 1999 |
| Poly (ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia F Moroni, E Meli, F Peruginelli, A Chiarugi, A Cozzi, R Picca, P Romagnoli, ... Cell Death & Differentiation 8 (9), 921-932, 2001 | 189 | 2001 |
| Nuclear poly (ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction G Cipriani, E Rapizzi, A Vannacci, R Rizzuto, F Moroni, A Chiarugi Journal of Biological Chemistry 280 (17), 17227-17234, 2005 | 178 | 2005 |
